|
1
|
Ljungberg B, Bensalah K, Canfield S,
Dabestani S, Hofmann F, Hora M, Kuczyk MA, Lam T, Marconi L,
Merseburger AS, et al: EAU guidelines on renal cell carcinoma: 2014
update. Eur Urol. 67:913–924. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Hadoux J, Vignot S and De La Motte Rouge
T: Renal cell carcinoma: Focus on safety and efficacy of
temsirolimus. Clin Med Insights Oncol. 4:143–154. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Gupta K, Miller JD, Li JZ, Russell MW and
Charbonneau C: Epidemiologic and socioeconomic burden of metastatic
renal cell carcinoma (mRCC): A literature review. Cancer Treat Rev.
34:193–205. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Margulis V, Master VA, Cost NG, Leibovich
BC, Joniau S, Kuczyk M, Mulders PF, Kirkali Z, Wirth MP, Hirao Y,
et al: International consultation on urologic diseases and the
European Association of Urology international consultation on
locally advanced renal cell carcinoma. Eur Urol. 60:673–683. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Bartel DP: MicroRNAs: Genomics,
biogenesis, mechanism, and function. Cell. 116:281–297. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Friedman RC, Farh KK, Burge CB and Bartel
DP: Most mammalian mRNAs are conserved targets of microRNAs. Genome
Res. 19:92–105. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Calin GA and Croce CM: MicroRNA signatures
in human cancers. Nat Rev Cancer. 6:857–866. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Yoshino H, Yonemori M, Miyamoto K,
Tatarano S, Kofuji S, Nohata N, Nakagawa M and Enokida H:
microRNA-210-3p depletion by CRISPR/Cas9 promoted tumorigenesis
through revival of TWIST1 in renal cell carcinoma. Oncotarget.
8:20881–20894. 2017.PubMed/NCBI
|
|
9
|
Sobin LH, Gospodarowicz MK and Wittenkind
C: TNM Classification of Malignant Tumour. 7th. Wiley-Liss Inc.;
New York: pp. 255–257. 2009
|
|
10
|
Li B and Dewey CN: RSEM: Accurate
transcript quantification from RNA-Seq data with or without a
reference genome. BMC Bioinformatics. 12:3232011. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Creighton CJ, Morgan M, Gunaratne PH,
Wheeler DA, Gibbs RA, Robertson A Gordon, Chu A, Beroukhim R,
Cibulskis K, Signoretti S, et al Cancer Genome Atlas Research
Network, : Comprehensive molecular characterization of clear cell
renal cell carcinoma. Nature. 499:43–49. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Cerami E, Gao J, Dogrusoz U, Gross BE,
Sumer SO, Aksoy BA, Jacobsen A, Byrne CJ, Heuer ML, Larsson E, et
al: The cBio cancer genomics portal: An open platform for exploring
multidimensional cancer genomics data. Cancer Discov. 2:401–404.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Gao J, Aksoy BA, Dogrusoz U, Dresdner G,
Gross B, Sumer SO, Sun Y, Jacobsen A, Sinha R, Larsson E, et al:
Integrative analysis of complex cancer genomics and clinical
profiles using the cBioPortal. Sci Signal. 6:pl12013. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Yoshino H, Chiyomaru T, Enokida H,
Kawakami K, Tatarano S, Nishiyama K, Nohata N, Seki N and Nakagawa
M: The tumour-suppressive function of miR-1 and miR-133a targeting
TAGLN2 in bladder cancer. Br J Cancer. 104:808–818. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Iorio MV and Croce CM: MicroRNA
dysregulation in cancer: Diagnostics, monitoring and therapeutics.
A comprehensive review. EMBO Mol Med. 4:143–159. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Ebert MS, Neilson JR and Sharp PA:
MicroRNA sponges: Competitive inhibitors of small RNAs in mammalian
cells. Nat Methods. 4:721–726. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Kloosterman WP, Lagendijk AK, Ketting RF,
Moulton JD and Plasterk RH: Targeted inhibition of miRNA maturation
with morpholinos reveals a role for miR-375 in pancreatic islet
development. PLoS Biol. 5:e2032007. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Stenvang J, Petri A, Lindow M, Obad S and
Kauppinen S: Inhibition of microRNA function by antimiR
oligonucleotides. Silence. 3:12012. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Wang GJ, Liu GH, Ye YW, Fu Y and Zhang XF:
The role of microRNA-1274a in the tumorigenesis of gastric cancer:
Accelerating cancer cell proliferation and migration via directly
targeting FOXO4. Biochem Biophys Res Commun. 459:629–635. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Sand M, Skrygan M, Sand D, Georgas D,
Gambichler T, Hahn SA, Altmeyer P and Bechara FG: Comparative
microarray analysis of microRNA expression profiles in primary
cutaneous malignant melanoma, cutaneous malignant melanoma
metastases, and benign melanocytic nevi. Cell Tissue Res.
351:85–98. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Zhou C, Liu J, Li Y, Liu L, Zhang X, Ma
CY, Hua SC, Yang M and Yuan Q: microRNA-1274a, a modulator of
sorafenib induced a disintegrin and metalloproteinase 9 (ADAM9)
down-regulation in hepatocellular carcinoma. FEBS Lett.
585:1828–1834. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Yan H, Wang S, Yu H, Zhu J and Chen C:
Molecular pathways and functional analysis of miRNA expression
associated with paclitaxel-induced apoptosis in hepatocellular
carcinoma cells. Pharmacology. 92:167–174. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Ezzie ME, Crawford M, Cho JH, Orellana R,
Zhang S, Gelinas R, Batte K, Yu L, Nuovo G, Galas D, et al: Gene
expression networks in COPD: microRNA and mRNA regulation. Thorax.
67:122–131. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Yoshino H, Enokida H, Itesako T, Tatarano
S, Kinoshita T, Fuse M, Kojima S, Nakagawa M and Seki N:
Epithelial-mesenchymal transition-related microRNA-200s regulate
molecular targets and pathways in renal cell carcinoma. J Hum
Genet. 58:508–516. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
García de Vinuesa A, Abdelilah-Seyfried S,
Knaus P, Zwijsen A and Bailly S: BMP signaling in vascular biology
and dysfunction. Cytokine Growth Factor Rev. 27:65–79. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Heldin CH, Miyazono K and ten Dijke P:
TGF-beta signalling from cell membrane to nucleus through SMAD
proteins. Nature. 390:465–471. 1997. View
Article : Google Scholar : PubMed/NCBI
|
|
27
|
Jang CW, Chen CH, Chen CC, Chen JY, Su YH
and Chen RH: TGF-beta induces apoptosis through Smad-mediated
expression of DAP-kinase. Nat Cell Biol. 4:51–58. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Halvorsen AR, Kristensen G, Embleton A,
Adusei C, Barretina-Ginesta MP, Beale P and Helland Å: Evaluation
of prognostic and predictive significance of circulating MicroRNAs
in ovarian cancer patients. Dis Markers 2017.
30985422017.doi.org/10.1155/2017/3098542.
|
|
29
|
Slattery ML, Trivellas A, Pellatt AJ,
Mullany LE, Stevens JR, Wolff RK and Herrick JS: Genetic variants
in the TGFβ-signaling pathway influence expression of miRNAs in
colon and rectal normal mucosa and tumor tissue. Oncotarget.
8:16765–16783. 2017.PubMed/NCBI
|
|
30
|
Allison SE, Chen Y, Petrovic N, Zimmermann
S, Moosmann B, Jansch M, Cui PH, Dunstan CR, Mackenzie PI and
Murray M: Activation of the pro-migratory bone morphogenetic
protein receptor 1B gene in human MDA-MB-468 triple-negative breast
cancer cells that over-express CYP2J2. Int J Biochem. 80:173–178.
2017. View Article : Google Scholar
|
